The global Organoids and Spheroids market was valued at US$ 0.781 billion in 2023 and is projected to reach US$ 6.40 billion by 2029, at a CAGR of 23.12% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Organoids and Spheroids market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Organoids and Spheroids market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Organoids and Spheroids market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Organoids are complex clusters of organ-specific cells such as stem cells or progenitor cells. Spheroids are simple clusters of broad-ranging cells such as tumor tissue, embryoid bodies.
Organoids and Spheroids Market aims to provide a comprehensive presentation of the global market for Organoids and Spheroids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organoids and Spheroids. Organoids and Spheroids Market contains market size and forecasts of Organoids and Spheroids in global, including the following market information:
- Global Organoids and Spheroids Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
by Organoids Type Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Organoids and Spheroids include Merck KGaA, ATCC, Corning Incorporated, Greiner Bio-One(Greiner Group AG), AMS Biotechnology (Europe) Limited, Lonza, Hubrecht Organoid Technology (HUB), 3D Biomatrix and 3D Biotek LLC, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Organoids and Spheroids companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Organoids and Spheroids Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Organoids and Spheroids Market Segment Percentages, by Type, 2023 (%)
by Organoids Type
- Neural Organoids
- Hepatic Organoids
- Intestinal Organoids
- Others
by Spheroids Type
- Multicellular Tumor Spheroids (MCTS)
- Neurospheres
- Mammospheres
- Hepatospheres
- Embryoid Bodies
Global Organoids and Spheroids Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Organoids and Spheroids Market Segment Percentages, by Application, 2023 (%)
- Biotechnology and Pharmaceutical Industries
- Academic and Research Institutes
- Hospitals and Diagnostic Centers
Global Organoids and Spheroids Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Organoids and Spheroids Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Organoids and Spheroids revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Organoids and Spheroids revenues share in global market, 2023 (%)
key players include:
- Merck KGaA
- ATCC
- Corning Incorporated
- Greiner Bio-One(Greiner Group AG)
- AMS Biotechnology (Europe) Limited
- Lonza
- Hubrecht Organoid Technology (HUB)
- 3D Biomatrix
- 3D Biotek LLC
- Cellesce Ltd.
- Prellis Biologics
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Organoids and Spheroids, market overview.
Chapter 2: Global Organoids and Spheroids market size in revenue.
Chapter 3: Detailed analysis of Organoids and Spheroids company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Organoids and Spheroids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Industry Market Size
